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ABSTRACT 
The recent advance in nanotechnology has lead to the development of targeted drug delivery system. However, targeting a molecule to a particular 
site using a drug delivery system effectively requires a specialized drug delivery system. The discovery of nanosponge has become a significant step 
in overcoming certain problems such as drug toxicity, poor bioavailability and release of drug in a predictable fashion as they can accommodate 
both hydrophilic and hydrophobic drug. Nanosponges exhibit a porous structure in nature which has the unique ability to entrap the drug moieties 
and offers a merit of desire release. Nanosponges are tiny sponges that can circulate in the body to reach the specific site and binds on the surface to 
release the drug in a controlled and predictable manner. Nanosponges can be formulated by crosslinking of cyclodextrine with carbonyl or di-
carboxylate (Crosslinkers). Nano sponge’s technology has been explored widely for the delivery of drugs for oral administration, topical 
administration, and parental administration. Nanosponges can also serve as an effective carrier for enzyme, proteins, vaccine and antibodies. The 
present review highlights the method of preparation, characterization and their potential application in drug delivery system.  
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INTRODUCTION  
To get intended result, targeting drug delivery systems have been an 
ambition for a prolonged period. In the beginning, Nanosponge drug 
delivery system appeared only as a topical delivery system, but in 
the 21st century, Nanosponges can be administered by oral as well 
as intravenous (IV) route [1]. 
Nanosponge is a modern category of material and is made up of tiny 
particles with a narrow cavity of few nanometers. These narrow 
cavities can be filled with various types of substances. These tiny 
particles are having a capability due to which it is able to carry both 
hydrophilic and lipophilic drug substance and can increase the 
stability of poorly water-soluble drug substance or molecules [2]. 
The nanosponges are a three-dimensional scaffold (backbone) or 
network of polyester that are capable of degrading naturally. These 
polyesters are mixed with a crosslinker in a solution to form 
Nanosponges. Here, the polyester is generally biodegradable, so it 
breaks down in the body moderately. Once the scaffold of 
nanosponges breaks down it releases the drug molecules which is 
loaded, in a derogatory fashion.  
 
 
Fig. 1: Structure of a nanosponge showing a cavity for drug 
loading [3] 
Advantages of nanosponges 
 Increase aqueous solubility of the poorly water-soluble drug. 
 Nanosponges can release the drug molecules in a predictable 
fashion. 
 Because of their tiny pore size (0.25 µm), bacteria cannot 
penetrate the nanosponges and they act like a self-sterilizer. 
 Nanosponges drug delivery system are non-irritating, non-
mutagenic and non-toxic. 
 Nanosponges help to remove the toxic and venom substance 
from the body. 
 Nanosponges drug delivery system minimize side effect. 
 Increase formulation stability and enhance the flexibility of the 
formulation. 
 Reduce dosing frequency. 
 Better patient compliance. 
 Nanosponges complexes are stable over wide range of pH (i.e. 1-
11) and a temperature of 130 °C [4-6]. 
Disadvantages of nanosponges 
 Nanosponges have the capacity of encapsulating small 
molecules, not suitable for larger molecules.  
 Dose dumping may occur at times [7]. 
Methods of preparation 
Solvent method  
 Using solvent method, Nano sponges are prepared by mixing 
polar aprotic solvents like Dimethyl sulfoxide (DMSO), 
Dimethylformamide (DMF) with the polymer. A crosslinker is then 
added to this mixture in the ratio of 1:4. The above reaction should 
be proceeded at temperature 10˚C to reflux the temperature of the 
solvent for the time ranging from 1 to 48 h. Once the reaction has 
completed, the solution is cooled down at room temperature and 
then obtained a product is added to bi-distilled water. The product is 
recovered by filtering the product under vacuum and refining by 
soxhlet extraction with ethanol followed by drying. 
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Table 1: Materials used in the preparation of nanosponges 
Polymer Copolymer Crosslinker 
Hyper cross-linked polystyrenes, 
cyclodextrine and its derivatives like 
methyl β-cyclodextrine, 
2-hydropropyl β-cyclodextrine. 
Ethyl cellulose (EC), 
polyvinyl alcohol 
(PVA),  
Di-phenyl Carbonate (DPC), diarylcarbonate, diisocyanates, 
pyromelliticanhydride, carbonyl diimidazole, 22-bis (acrylamide) acidic 
acid and dichloromethane. [8, 9] 
 
Ultra-sound assisted synthesis  
Polymers are made to react with crosslinkers in a flask without the 
solvent. The flask is placed in an ultrasound bath which is filled with 
water and heated up to 90˚C and the mixture is sonicated for 5 h. 
Then the mixture is cooled down to room temperature and then the 
product is broken into rough pieces. At last, the non-reacting 
polymer is removed by washing the product with water and refining 
is done using soxhlet apparatus (ethanol) to obtain nanosponges 
[10].
 
 
Fig. 2: Flow diagram for the preparation of nanosponges by ultrasound-assisted method 
 
Emulsion solvent diffusion method  
In this method, different proportion or amount of ethyl cellulose 
and polyvinyl alcohol are used to prepare nanosponges. Two 
phases are used in this method–dispersed and continuous. The 
dispersed phase consists of ethyl cellulose and the drug, which is 
then dissolved in 20 ml of dichloromethane and some amount of 
polyvinyl alcohol (PVA) is added to 150 ml of the continuous 
phase (aqueous). Then, the mixture is stirred at the speed of 
1000 rpm for about 2 h. The product i.e. the nanosponges are 
collected by filtration. Finally, the product is dried inanoven at a 
temperature of 400˚C [11]. 
Loading of drug into nanosponges 
To obtain the particle size less than 500 nm, nanosponges should be 
pre-treated. To obtain this range, the nanosponges are dissolved or 
suspended in water. The suspended nanosponges are sonicated 
vigorously to prevent the accumulation. The suspension is 
centrifuged to produce a colloidal fraction. The supernatant is 
separated and the sample is dried using a freeze dryer. 
An aqueous suspension of nanosponges is prepared. An excess 
amount of drug is added to the suspension and continuously stirred 
for the certain period of time for the complexation to occur. After the 
complexation has taken place, the uncomplexed drug is separated 
from the complexed drug by using centrifugation. The solid crystals 
of the nanosponges are obtained by using a freeze dryer or by 
evaporating the solvent. 
This Solid Crystal structure of nanosponges has a crucial rule in 
complexation of the drug. The drug loading capacities of 
paracrystalline nanosponges is lesser when compared to crystalline 
nanosponges. The drug loading takes place as a mechanical mixture 
in weakly crystalline nanosponges [12]. 
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Mechanism of drug release from nanosponges 
Since the nanosponges have an open structure (in the surrounding of 
nanosponges they do not have any continuous membrane), the active 
substance is added to the vehicle in an encapsulated form. The 
encapsulated active substance is able to move freely from the particles 
into the vehicle until the vehicle gets saturated and the equilibrium is 
obtained. As soon as the product is applied on to the skin, the vehicle 
containing the active ingredient gets unsaturated causing a disturbance 
in the equilibrium. Thus, the flow of active substances from nanosponge 
particles into vehicles starts to epidermis until the vehicle is either 
absorbed or dried. Even after the retention of the nanosponge particles 
on the surface of skin i.e. the stratum corneum, the release of active 
substance continues to skin for a long period of time. 
Factors influencing in the formulation of nanosponges 
Nature of polymer 
The polymer used in the preparation of nanosponges can influence 
its formation and can also affect the pre-formulation. The size of the 
cavity of a nanosponge should be big enough to entrap a drug 
molecule of a particular size into it for complexation [13]. 
Drug  
To be complex with nanosponges, the drug molecules should have 
some specific characteristics as mentioned below:  
• The molecular weight of the drug molecule should be in range 
ranging from 100-400 Daltons. 
• Structure of drug molecule should not consist of more than 5 
condensed ring. 
• The solubility of thedrug in water should be<10 mg/ml. 
• The melting point of the drug should be <250 ˚ C. 
Temperature 
Changes in the temperature can affect the complexation of drug or 
nanosponges. Increasing the temperature generally decreases the 
extent of the stability constant of the drug or the nanosponge 
complex which may be due to the reduction of interaction forces 
such as hydrophobic forces and Van der Waal forces of 
drug/nanosponges with an increase in the temperature [14]. 
Degree of substitution 
The number, position, and type of the substituent of the parent 
molecule can affect the ability of complexation of the nanosponges to 
a greater extent [15]. 
Method of preparation 
The method of drug loading into the nanosponges can cause a change 
in the complexation of drug and the nanosponges. Although, the 
success of a method mainly depends on the nature or the 
characteristics of the drug and polymer; in some cases, freeze drying 
has also been known to affect the drug and nanosponge complexation. 
Characterization of nanosponges 
The characterization methods for the complexed drug/nanosponges 
are listed below:  
Solubility studies  
Inclusion complexes is a technique by which can determine the 
solubility and bioavailability of the drug. This technique is the most 
widely approached technique for analysis of the inclusion complexes 
of nanosponges. Degree of completion can be known by the plot of 
phase solubility. Solubility studies are conducted to access the pH of 
the drug, solubilization outline and to evaluate the factors affecting 
drug solubility [16]. 
Microscopic study 
Microscopic studies of nanosponges/drug can be conducted by using 
scanning electron microscope and transmission electron 
microscope. Inclusion complex formation is indicated by the 
difference in the crystallization state and the product seen under an 
electron microscope. 
Zeta potential determination  
Zeta potential can be defined as the difference of potential between two 
layers (dispersion medium and immobile layer) of fluid locked up with 
dispersed particles. Zeta potential is the major key indicator for the 
stability of the colloidal dispersion. By adding extra electrode on particle 
size equipment or zeta seizer, the zeta potential can be measured. Higher 
the value of zeta potential of a colloidal dispersion more is its stability. 
Thermodynamical method 
If any changes occur in drug molecules or particles undergoes some 
changes earlier then the thermal degradation of nanosponges it can 
be determined by the thermo-chemical method. The changes of drug 
particles can be melting, evaporation, oxidation and decomposition 
and polymeric changes. The changes in the drug molecules indicate 
the formation of a good complex. 
Particle size and polydispersity 
Particles size is determined by the process of dynamic light 
scattering using 90Plus particle size determining software. Dynamic 
light scattering (DLS) is defined as a technique used to find out the 
size distribution profile of nanoparticles. At last, the final diameter of 
the particles and poly-dispersity index (PDI) can be found. 
Thin layer chromatography (TLC)  
TLC can be defined as a technique which can be used to separate the 
non-volatile or evaporative mixture. In this technique, if the Rf value of a 
particular drug molecule is of an acceptable range then it is helpful in 
recognizing the formation of a complex between drug and nanosponges. 
Infrared spectroscopy 
The interaction between nanosponges and the drug in the solid state 
can be determined by using infrared spectroscopy. Nanosponge 
bands can slightly change during formation of complexes. Few guest 
molecules attached in the complexes which are less than 25%, the 
drug spectrum can be easily masked by the spectrum of 
nanosponges. The technique is not appropriate to identify the 
inclusion complex over the other methods [17]. 
Loading efficiency 
The loading efficiency of a nanosponge particle can be determined 
by the estimation of drug loaded into the nanosponge using UV 
spectrophotometer and high-performance liquid chromatography 
method for the nanosponges. The loading efficiency of nanosponges 
can be calculated by using the following equation. 
 
Application of nanosponges  
Nanosponges have a wide range of application in the pharmaceutical 
field, because of its biocompatibility and versatility. In the 
pharmaceutical industry, nanosponges can be used as an excipient for 
the formulation of tablets, capsules, granules, pallets, suspensions, solid 
dispersions and topical dosage forms. Nanosponges can accommodate 
both lipophilic and hydrophilic drug molecules, basically, those drugs 
substances which belong to the biopharmaceutical classification system 
(BCS-class II) as well as the poorly water-soluble drug [18]. 
Nanosponges for drug delivery 
Nanosponges can carry the water-insoluble drug because of their 
tiny porous structure. To increase the dissolution rate, solubility and 
permeability of drug nanosponges complexes play a major role. This 
is reported that β-cyclodextrine based nanosponges are three or five 
times more effective to deliver the drug to the targeted site. 
Nanosponges are generally solid in nature and can be prepared for 
oral, parental, topical and inhalation dosage form. For the 
preparation of tablet, capsule i.e. oral administration the 
nanosponges complexes are dissolved in a suitable excipient like 
lubricants, diluents and anti-cracking agent. 
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Table 2: List of drug molecules encapsulated with nanosponges 
Category Nanosponges vehicle Drugs Reference 
Anticancer β–Cyclodextrine Paclitaxel Camptothecin 18 
Breast cancer β-Cyclodextrine Tamoxifen 18 
Inflammation β-Cyclodextrine Resveratrol 18 
Brain tumor Poly (valerolactoneallylvalerolactone) and poly 
(valerolactoneallylvalerolactone –oxepanedione) 
Temozolamide 19 
Antifungal Ethyl cellulose Polyvinyl alcohol Econazole nitrate 19 
 β-Cyclodextrine Itraconazole 19 
Cancer therapy Sodium alginate Antisense 20 
Brain tumor β-Cyclodextrine Dexamethasone 20 
Oligonucleotides Poly L-lysine Viral infection 
Pathologic disorder  
20 
Nanosponges have several properties that boost the product performance and elegance, controlled release, sustained release, decrease skin 
irritation, improve solubility and increase product flexibility. 
 
Nanosponges for cancer therapy 
Most challenging works nowadays in the pharmaceutical field is the 
delivery of anticancer drug because of their low solubility. In one article 
they claim that nanosponge’s complex is three times more effective to 
reduce the growth of tumor then direct injection. The nanosponge’s 
complex load with a drug and expose a targeting peptide that fastens 
tightly with a radiation-induced cell upper layer on the tumor receptor. 
When nanosponges confront the tumor cell they stuck on the surface of 
tumor cell and start to release the drug molecules. The advantage of 
targeting drug delivery is to get a more effective therapeutic effect at the 
same dose and with minimized side effect [21]. 
Nanosponges for delivery of protein 
To study the encapsulating capacity of β-cyclodextrin-based 
nanosponges, bovine serum albumin (BSA) was used as a model 
protein. Protein solution of bovine serum albumin (BSA) is not 
stable so they are stored in lyophilized form. Proteins can convert to 
denatured on lyophilization from its native structure. For the 
formulation and development of protein, the major drawback is that 
to maintain its native structure and long-term storage during and 
after processing. For delivery of the protein like Bovine serum 
albumin (BSA) with the cyclodextrine based, nanosponges can 
increase the stability of these proteins. Nanosponges have also been 
used for immobilization of enzyme, encapsulation of protein, for 
controlled delivery and stabilization [22]. 
Role of nanosponges for treatment of fungal infections 
Fungal infections of the skin are one of the dangerous diseases in 
worldwide [23]. Topical therapy is an attractive choice for the 
treatment of the coetaneous infections due to various advantages 
such as targeting of drugs to the direct site of infection and reduction 
of systemic side effects. Econazole nitrate (imidazole) is an 
antifungal or pharmaceutical fungicide used topically to cure 
athlete’s foot, ringworm, tineapityriasis versicolor, jock itch and 
vaginal thrush. The available products of econazole nitrate present 
in the market are cream, ointment, lotion, and solution. Adsorption 
of econazole nitrate is not significant when it is applied to the skin 
and effective therapy; need a high concentration of active agents to 
be combined. For this reason, econazole nitrate nanosponges were 
fabricated by emulsion solvent method and these econazole nitrate 
nanosponges were loaded in a hydrogel as a topical delivery for 
sustained release of the drug [24-25]. 
Itraconazole is also an antifungal drug comes under biopharmaceutical 
classification system class II and that has a dissolution rate limited and 
poor bioavailability. So the aim of this study was to increase the 
solubility of the itraconazole, so that can solve the bioavailability 
problem. In these nanosponges, if used β-cyclodextrine as cross-linked 
with carbonate bonds and loaded it with itraconazole than the solubility 
of itraconazole can be increased. 
As absorbent in treating poison in blood 
Nanosponges can remove the dangerous poisonous substance from 
our blood by absorbing the poison. Instead of using antidotes, if we 
incorporate nanosponges by injection into blood nanosponges can 
soak up the toxins. In the bloodstream, the nanosponge looks like a 
red blood cell, tricks toxins into attacking it, and then absorbs it. The 
number of toxin molecules each nanosponge can absorb depends on 
the toxin [26]. 
CONCLUSION 
Nanosponges have been recognized as drug delivery system to 
encapsulate or accumulate for both hydrophilic and lipophilic drug 
by forming a complex. They can effectively deliver the drug in a 
controlled manner at a target site. Nanosponges can be incorporated 
into topical preparation such as lotions, cream, ointments etc. And 
liquid or powder form. The advantage of this technology offers 
targeting the drug to specific site reduces side effects, improve 
stability, and improve formulation flexibility and better patient 
compliance. Nanosponges offer application in other areas such as 
cosmetics, biomedicine, bioremediation process, agrochemistry,and 
catalysis etc. 
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